<DOC>
	<DOCNO>NCT00822367</DOCNO>
	<brief_summary>The purpose study determine commonly use meal supplement best product patient DM . This important meal supplement become popular meal replacement United States . Peak blood sugar occur 2 hour later meal . Therefore , best product would one produce small rise blood sugar .</brief_summary>
	<brief_title>Blood Sugar Response Commercial Nutritional Supplements Patients With Type 2 Diabetes</brief_title>
	<detailed_description>The purpose study determine commonly use commercial nutritional supplement preferential patient Diabetes Mellitus ( DM ) . We compare post-prandial blood glucose ( BG ) responses response 3 different nutritional supplement contain 50 gram carbohydrate adult patient type 2 diabetes mellitus relate response one two well-recognized index insulin sensitivity - HOMA-R QUICKI .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Ages 1875 year Type2 diabetes mellitus 3 month A1c 7.0 10.0 % within past 3 month Controlled diet /exercise and/or oral antidiabetic agent noninsulin secretatgogues , i.e . Metformin and/or Pioglitazone Able give inform consent Expected DC metropolitan duration study Fasting blood glucose 70 250 mg/dl Patients type 2 diabetes mellitus treat insulin secretagogues ( sulfonylurea nonsulfonylurea ) , pramlintide ( Symlin ) , GLP1 analog ( Byetta ) , insulin , alphaglycosidase inhibitor A1c 7.0 % 10.0 % Fasting blood glucose &lt; 70 &gt; 250 mg/d Gastrointestinal disorder affect digestion absorption nutrient lactose intolerance , chronic diarrhea , pancreatic insufficiency . Clinical history document gastroperesis . Patients hemodialysis peritoneal dialysis Pregnancy Inability read and/or speak English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>